Involvement of matrix metalloproteinases in human immunodeficiency virus type 1-induced replication by clinical Mycobacterium avium isolates

Journal of Infectious Diseases

Volumn 180, Issue 4, 1999, Pages 1142-1152

  Dezzutti, Charlene S ^a   Edward Swords, W ^a   Guenthner, Patricia C ^a   Sasso, Donna R ^a   Wahl, Larry M ^b   Drummond, Alan H ^c   Newman, Gale W ^a,d   Harold King, C ^a,e   Quinn, Frederick D ^a   Lal, Renu B ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c British Biotech Pharmaceuticals Ltd   (United Kingdom)

^d MOREHOUSE SCHOOL OF MEDICINE   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; GELATINASE B; MATRIX METALLOPROTEINASE; PROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CELL ACTIVATION; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; VIRUS REPLICATION;

ANIMALS; CELL LINE; CELLS, CULTURED; HIV CORE PROTEIN P24; HIV PROTEASE; HIV-1; HUMANS; KINETICS; LYMPHOCYTE DEPLETION; LYMPHOCYTES; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; PENTOXIFYLLINE; SEROTYPING; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUBERCULOSIS; VIRUS REPLICATION;

EID: 0033370657     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314992     Document Type: Article

References (53)

1. Crowle AJ, Tsang AY, Vetter AE, May MH. Comparison of 15 laboratory and patient-derived strains of Mycobacterium avium for ability to infect and multiply in cultured human macrophages. J Clin Microbiol 1986;24:812-21.
2. Newman GW, Gan HX, McCarthy PL Jr, Remold HG. Survival of human macrophages infected with Mycobacterium avium intracellulare correlates with increased production of tumor necrosis factor-α and IL-6. J Immunol 1991;147:3942-52.
3. Michelini-Norris MB, Blanchard DK, Pearson CA, Djeu JY. Differential release of interleukin (IL)-lα, IL-1β, and IL-6 from normal human monocytes stimulated with a virulent and an a virulent isogeneic variant of Mycobacterium avium intracellulare complex. J Infect Dis 1992;165:702-9.
4. Kinter AL, Poli G, Fox L, Hardy E, Fauci AS. HIV replication in IL-2 stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cytokines. J Immunol 1995;154:2448-59.
5. Poli G, Kinter AL, Vicenzi E, Fauci AS. Cytokine regulation of acute and chronic HIV infection in vitro from cell lines to primary mononuclear cells. Res Immunol 1994;145:578-82.
6. Ghassemi M, Andersen BR, Reddy VM, Gangadharam PRJ, Spear GT, Novak RM. Human immunodeficiency virus and Mycobacterium avium complex coinfection of monocytoid cells results in reciprocal enhancement of multiplication. J Infect Dis 1995;171:68-73.
7. Shiratsuchi H, Johnson JL, Toossi Z, Ellner JJ. Modulation of the effector function of human monocytes for Mycobacterium avium by human immunodeficiency virus 1 envelope glycoprotein gp120. J Clin Invest 1994;93:885-91.
8. Yakrus MA, Good RC. Geographic distribution, frequency, and specimen source of M. avium complex serotypes isolated from patients with acquired immunodeficiency syndrome. J Clin Microbiol 1990;28:926-9.
9. Reddy VM, Parikh K, Luna-Herrera H, Falkinham JO III, Brown S, Gangadharam PRJ. Comparison of virulence of Mycobacterium avium complex (MAC) strains isolated from AIDS and non-AIDS patients. Microb Pathog 1994;16:121-30.
10. Gangadharam PR, Reddy MV. Contributions of animal and macrophage models to the understanding of host parasite interactions of Mycobacterium avium complex (MAC) disease. Res Microbiol 1994;145:214-24.
11. Birkedal-Hansen H, Moore WB, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
12. Reynolds JJ. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation. Oral Dis 1996;2:70-6.
13. Goetzl EJ, Banda MJ, Leppert D. Matrix metalloproteinases in immunity. J Immunol 1996;156:1-4.
14. Dayer JM. Regulation of IL-1/TNF, their natural inhibitors, and other cytokines in chronic inflammation. Immunologist 1997;5/6:192-201.
15. Dhawan S, Weeks BS, Soderland C, et al. HIV-1 infection alters monocyte interaction with human microvascular endothelial cells. J Immunol 1995;154:422-32.
16. Lafrenie RM, Wahl LM, Epstein JS, Hewlett IK, Yamada KM, Dhawan S. HIV-1 Tat protein promotes chemotaxis and invasive behavior by monocytes. J Immunol 1996;157:974-7.
17. Folks T, Benn S, Rabson A, et al. Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS) associated retrovirus. Proc Natl Acad Sci USA 1985;82:4539-43.
18. Xiao L, Owen SM, Goldman I, et al. CCR5 coreceptor usage of non syncytium-inducing primary IIIV-1 is independent of phylogenetically distinct global IIIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage. Virology 1998;240:83-92.
19. Bermudez LE, Young LS. Natural killer cell dependent mycobacteriostatic and mycobactericidal activity in human macrophages. J Immunol 1991;146:265-70.
20. Gun H, Newman GW, Remold HG. Human macrophages acquire a hyporesponsive state of tumor necrosis factor alpha production in response to successive Mycobacterium avium serovar 4 stimulation. Infect Immun 1995;63:1921-6.
21. Xiao L, Owen SM, Rudolph DL, Lal RB, Lal AA. Plasmodium falciparum antigen induced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor-α. J Infect Dis 1998;177:437-45.
22. Dezzutti CS, Sasso DR, Rudolph DL, Lal RB. Down-regulation of interleukin-10 expression and production is associated with spontaneous proliferation by lymphocytes from human T lymphotropic virus type II-infected persons. J Infect Dis 1998;177:1489-96.
23. Butera ST, Perez VL, Wu BY, Nabel GJ, Folks TM. Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4 cell model of chronic infection. J Virol 1991;65:4645-53.
24. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 1997;185:621-8.
25. Mutis T, Cornelisse YE, Ottenhoff TH. Mycobacteria induce CD4 T cells that are cytotoxic and display Th1-like cytokine secretion profile: heterogeneity in cytotoxic activity and cytokine secretion levels. Eur J Immunol 1993;23:2189-95.
26. Munk ME, Emoto M, Functions of T-cell subsets and cytokines in mycobacterial infections. Eur Respir J 1995;20(Suppl):668s-75s.
27. Gallea-Robache S, Morand V, Millet S, et al. A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells. Cytokine 1997;9:340-6.
28. Monaco JA, Kinter A, Fox L, Hardy F, Fauci AS. Effect of a tumor necrosis factor protease inhibitor, BB-2H6, on in vitro HIV replication [abstract 458]. In: Program and abstracts 3rd Conference on Retroviruses and Opportunistic Infections (Washington, DC). Alexandria, VA: Infectious diseases Society of America. 1996.
29. Wallis RS, Nsubuga P, Whalen C, et al. Pentoxifylline therapy in human immunodeficiency virus-seropositive persons with tuberculosis: a randomized, controlled trial. J Infra Dis 1996;174:727-33.
30. Mackewicz C, Levy JA. CD8′ cell anti-HIV activity: nonlytic suppression of virus replication. AIDS Res Hum Retrovirus 1992;8:1039-50.
31. Folks TM, Kelly J, Benn S, et al. Susceptibility of normal human lymphocytes to infection with HTLV III/LAV. J Immunol 1986;136:4049-56.
32. Bukrinsky MI, Stanwick TL, Dempsey MP, Stevenson M. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 1991;254:423-7.
33. Zagury D, Bernard J, Leonard R, et al. Long-term cultures of HTLV-III-infected T cells: a model of cytopathology of T-cell depletion in AIDS. Science 1986;231:850-3.
34. Weissman D, Barter TD, Fauci AS. The efficiency of acute infection of CD4′ T cells is markedly enhanced in the setting of antigen-specific immune activation. J Exp Med 1996;183:687-92.
35. O'Brian WA, Grovit-Ferbas K, Namazi A, et al. Human immunodeficiency virus type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995;86:1082-9.
36. Stanley SK, Ostrowski MA, Justement JS, et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 1996;334:1222-30.
37. Havlir DV, Haubrich R, Hwang J, et al. Human immunodeficiency virus replication in AIDS patients with Mycobacterium avium complex bacteremia: a case control study. J Infect Dis 1998;177:595-9.
38. Haas DW, Lederman MM, Clough LA, et al. Proinflammatory cytokine and human immunodeficiency virus RNA levels during early Mycobacterium avium complex bacteremia in advanced AIDS. J Infect Dis 1998;177:1746-9.
39. Goletti D, Weissman D, Jackson RW, et al. Effect of Mycobacterium tuberculosis on HIV replication: role of immune activation. J Immunol 1996;157:1271-8.
40. Toossi Z, Sierra-Madero JG, Blinkhorn RA, Mettler MA, Rich EA. Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1. J Exp Med 1993;177:1511-6.
41. Boom WH. The role of T-cell subsets in Mycobacterium tuberculosis infection. Infect Agents Dis 1991;5:73-81.
42. Ravn P, Pedersen BK. Mycobacterium avium and purified protein derivative-specific cytotoxicity mediated by CD4′ lymphocytes from healthy HIV-seropositive and -seronegative individuals. J Aquir Immune Defic Syndr Hum Retrovirol 1996;12:433-41.
43. Boom WH, Balaji RN, Nayak R, Tsukaguchi K, Chervenak KA. Characterization of a 10- to 14-kilodalton protease-sensitive Mycobacterium tuberculosis H37Ra antigen that stimulates human gamma delta T cells. Infect Immun 1994;62:5511-8.
44. Mehrotra J, Bisht D, Tiwari VD, Sinha S. Serological distinction of integral plasma membrane proteins as a class of mycobacterial antigens and their relevance for human T cell activation. Clin Exp Immunol 1995;102:626-34.
45. Poli G, Kinter A, Justement JS, et al. Tumor necrosis factor α functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sci USA 1990;87:782-5.
46. Butera ST, Roberts BD, Folks TM. Regulation of HIV-1 expression by cytokine networks in a CD4′ model of chronic infection. J Immunol 1993;150:625-34.
47. Poli G, Fauci AS. Cytokine modulation of HIV expression. Semin Immunol 1993;5:165-73.
48. Andreana A, Gallapudi S, Kim CH, Gupta S. Salmonella typhimurium activates human immunodeficiency virus type 1 in chronically infected promonocytic cells by inducing tumor necrosis factor-α production. Biochem Biophys Res Commun 1994;201:16-23.
49. Bernier R, Turco SJ, Olivier M, Tremblay M. Activation of human immunodeficiency virus type I in monocytoid cells by the protozoan parasite Leishmania donavani. J Virol 1995;69:7282-5.
50. Van Wan HE, Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 1990;87:5578-82.
51. Goldberg GI, Marmer BL, Grant GA, Eisen AZ, Wilhelm S, He C S. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteinases designated TIMP-2. Proc Natl Acad Sci USA 1989;86:8207-11.
52. Goldberg GL, Strongin A, Collier IE, Genrich LT, Manner BL. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 1992;267:4583-91.
53. Chang JC, Wysocki A, Tchou-Wong KM, Moskowitz N, Zhang Y, Rom WN. Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases. Thorax 1996;51:306-11.